Suspension of human autologous MSC 3P in 1.5 ml

BIOLOGICAL2 trials

Sponsors

Bioinova, s.r.o.

Conditions

Degenerative Disc DiseaseMotor Neuron Disease, Amyotrophic Lateral Sclerosis

Phase 1

Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease

TerminatedNCT03827096

Bioinova, s.r.o.Degenerative Disc Disease

Start: 2013-08-27End: 2016-12-14Updated: 2020-01-18

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

CompletedNCT03828123

Bioinova, s.r.o.Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Start: 2012-01-31End: 2017-08-18Updated: 2019-02-12